Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01811212
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:57.737680+00:00
Published At
2018-04-03T00:00:00+00:00
Record Updated At
2018-04-03
Results Posted At
2018-04-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Poorly Differentiated Thyroid Gland Carcinoma", "Recurrent Thyroid Gland Carcinoma", "Stage I Thyroid Gland Follicular Carcinoma", "Stage I Thyroid Gland Papillary Carcinoma", "Stage II Thyroid Gland Follicular Carcinoma", "Stage II Thyroid Gland Papillary Carcinoma", "Stage III Thyroid Gland Follicular Carcinoma", "Stage III Thyroid Gland Papillary Carcinoma", "Stage IVA Thyroid Gland Follicular Carcinoma", "Stage IVA Thyroid Gland Papillary Carcinoma", "Stage IVB Thyroid Gland Follicular Carcinoma", "Stage IVB Thyroid Gland Papillary Carcinoma", "Stage IVC Thyroid Gland Follicular Carcinoma", "Stage IVC Thyroid Gland Papillary Carcinoma", "Tall Cell Variant Thyroid Gland Papillary Carcinoma", "Thyroid Gland Oncocytic Follicular Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-04-03"
protocolSection.identificationModule.nctId
"NCT01811212"
protocolSection.identificationModule.officialTitle
"Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-04-03"

Study condition terms

  • Poorly Differentiated Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Thyroid Gland Follicular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Tall Cell Variant Thyroid Gland Papillary Carcinoma (protocolSection.conditionsModule.conditions)
  • Thyroid Gland Oncocytic Follicular Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.